How To Invest In Oxford Nanopore Technologies Shares IPO
New IPO: Oxford Nanopore Technologies founded in 2005 and a spin out from Oxford University is a specialist in developing DNA sequencing technologies.
Launch: IPO in the London Stock Exchange expected in 2nd half of 2021.
Many investors are looking forward to the IPO of Oxford Nanopore Technologies, which is expected to be priced at $3.2 billion. It is one of the few “unicorns” in the UK, according to this estimate.
Oxford Nanopore is a private company with its head quarters in the Oxford Science Park outside Oxford, UK, with satellite offices in Cambridge (UK), New York, Cambridge, San Francisco (US), Singapore, Shanghai, Beijing, and a broader commercial presence that includes Japan, Germany, France and India.
The company sells to more than 100 countries and is in a period of rapid growth.
Financial performance of Oxford Nanopore Technologies before the IPO
Oxford Nanopore Technologies was valued at $3.2 billion in March 2021. The investment firm IP Group, which owns 15% of Oxford Nanopore Technologies, estimated its assets to be worth more than $470 million.
Other investors in the company include Amgen, the sovereign wealth fund GIC, and China Construction Bank International.
According to company representatives, going public will allow the company to attract international capital while also realizing its active growth and production expansion ambitions.
Potential market and IPO prospects of Oxford Nanopore Technologies
Since the beginning of the COVID-19 pandemic, scientists in more than 85 countries have used the company’s technologies to track new mutations in the coronavirus.
The company’s MinIO device, which costs only $1,000, enables specialists to work without the assistance of large laboratories.
Oxford Nanopore Technologies also created a COVID-19 test that produces results in under an hour.
According to Grand View Research, the DNA sequencing market was valued at $ 4.7 billion in 2019 and is expected to grow to $ 11.2 billion by 2027.
The ongoing active phase of the pandemic, which, even with optimistic projections, is unlikely to end before 2022, is another factor influencing demand for the company’s services.
As a result, there is every reason to believe that Oxford Nanopore Technologies will continue to expand aggressively.
How to participate in the Oxford Nanopore Technologies IPO
Interested in investing in the Oxford Nanopore Technologies IPO?
Sign up with Freedom 24 using their form below to get regular updates on the Nanopore Technologies IPO.
We recommend you opening an investment account right away: the account verification process after that may take some time, and you may miss it, as the exact Oxford Nanopore Technologies IPO date will be known just a few days before the trading starts.
Please note: Oxford Nanopore Technologies is not yet a public company. Sign up now through Freedom 24 and they will notify you once the security issue memo is available and buying shares in the company is possible.
No news, feature article or comment should be seen as a personal recommendation to invest. Prior to making any decision to invest, you should ensure that you are familiar with the risks associated with a particular plan. If you are at all unsure of the suitability of a particular product, both in respect of its objectives and its risk profile, you should seek independent financial advice.
The value of shares, ETFs and ETCs bought through a share dealing account, a stocks and shares ISA or a SIPP can fall as well as rise, which could mean getting back less than you originally put in. Past performance is no guarantee of future results.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 67%-71% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money. Professional clients can lose more than they deposit. All trading involves risk.